Growing community of inventors

Houston, TX, United States of America

Prashi Jain

Average Co-Inventor Count = 7.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Prashi JainBert W O'Malley (3 patents)Prashi JainNoel Terrence Southall (25 patents)Prashi JainKevin Frankowski (13 patents)Prashi JainMarc Ferrer (11 patents)Prashi JainDavid Michael Lonard (3 patents)Prashi JainDavid Robert Sibley (8 patents)Prashi JainBryan Nikolai (3 patents)Prashi JainYosef Gilad (3 patents)Prashi JainClifford Dacso (3 patents)Prashi JainR Benjamin Free (3 patents)Prashi JainSang Jun Han (3 patents)Prashi JainJennie L Conroy (0 patent)Prashi JainKathryn D Luderman (0 patent)Prashi JainJeffrey AubÉ (0 patent)Prashi JainPrashi Jain (3 patents)Bert W O'MalleyBert W O'Malley (39 patents)Noel Terrence SouthallNoel Terrence Southall (25 patents)Kevin FrankowskiKevin Frankowski (13 patents)Marc FerrerMarc Ferrer (11 patents)David Michael LonardDavid Michael Lonard (11 patents)David Robert SibleyDavid Robert Sibley (8 patents)Bryan NikolaiBryan Nikolai (3 patents)Yosef GiladYosef Gilad (3 patents)Clifford DacsoClifford Dacso (3 patents)R Benjamin FreeR Benjamin Free (3 patents)Sang Jun HanSang Jun Han (3 patents)Jennie L ConroyJennie L Conroy (0 patent)Kathryn D LudermanKathryn D Luderman (0 patent)Jeffrey AubÉJeffrey AubÉ (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Baylor College of Medicine (3 from 600 patents)

2. National Institutes of Health, a Component of the US Dept. of Health & Human Services (3,435 patents)

3. The University of North Carolina at Chapel Hill (1,270 patents)

4. University of Kansas (547 patents)


3 patents:

1. 11633428 - Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

2. 11633429 - Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

3. 11497772 - Targeting of SRC-3 in immune cells as an immunomodulatory therapeutic for the treatment of cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…